[ad_1] Sanofi-aventis Korea has announced that its next generation of basal insulin, TJEZO Solostar (name of the ingredient: insulin glazine, 300 U / mL gene recombination), at the annual conference of the …
Read More »[메디파나뉴스]Tuzeo, EASD has proven that the patient's glycemic control is adapted to the insulin dose
